onc201
Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors
Neuro Oncol. 2021 PMID: 32830856
Chimerix is now part of Jazz Pharmaceuticals. Learn more at www.jazzpharma.com
onc201